↓ Skip to main content

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

Overview of attention for article published in The Lancet Respiratory Medicine, November 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
2 news outlets
twitter
8 X users
facebook
1 Facebook page
guideline
5 clinical guideline sources

Readers on

mendeley
267 Mendeley